Dynamic Regulation of the L-Proline Pathway for Efficient L-Arginine Production in Escherichia coli

被引:0
|
作者
Wang, Lijuan [1 ,2 ]
Yang, Kun [1 ,2 ]
Zhang, Zhi [1 ,2 ]
Ye, Weijie [1 ,2 ]
Guo, Yingying [1 ,2 ]
Yu, Haonan [1 ,2 ]
Liu, Zhiqiang [1 ,2 ]
Zheng, Yuguo [1 ,2 ]
机构
[1] Zhejiang Univ Technol, Natl & Local Joint Engn Res Ctr Biomfg Chiral Chem, Hangzhou 310014, Zhejiang, Peoples R China
[2] Zhejiang Univ Technol, Coll Biotechnol & Bioengn, Key Lab Bioorgan Synth Zhejiang Prov, Hangzhou 310014, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
E; coli; metabolic engineering; <sc>l</sc>-arginine; <sc>l</sc>-proline; dynamicregulation; L-ARGININE; METABOLISM;
D O I
10.1021/acs.jafc.4c07829
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
l-Arginine, a semiessential amino acid crucial for human health, has broad applications in cosmetics, nutraceuticals, feed, and pharmaceuticals. In this study, we developed an Escherichia coli strain with enhanced l-arginine production by deregulating negative feedback, enhancing the synthesis pathway, and increasing precursor and cofactor availability. The engineered strain achieved titers of 6.41 g/L in shake flasks and 63.9 g/L with a yield of 0.31 g/g of glucose in a 5 L fermenter. Blocking the competitive l-proline synthesis pathway elevated the l-arginine titer to 9.36 g/L but reduced the biomass. To fine-tune l-proline synthesis without exogenous l-proline, we developed a dynamic regulatory method for proB gene control. The final strain, harboring proB driven by a temperature-sensitive promoter, achieved 65.6 g/L l-arginine with a yield of 0.42 g/g glucose in a 5 L fermenter. Balancing growth and production through dynamic regulation of the l-proline pathway presents a viable strategy for refining l-arginine bioproduction.
引用
收藏
页码:3536 / 3545
页数:10
相关论文
共 50 条
  • [1] Metabolic engineering of Escherichia coli for efficient production of L-arginine
    Wang, Hai-De
    Xu, Jian-Zhong
    Zhang, Wei-Guo
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2022, 106 (17) : 5603 - 5613
  • [2] Metabolic engineering of Escherichia coli for efficient production of l-arginine
    Hai-De Wang
    Jian-Zhong Xu
    Wei-Guo Zhang
    Applied Microbiology and Biotechnology, 2022, 106 : 5603 - 5613
  • [3] A novel strategy for l-arginine production in engineered Escherichia coli
    Nie, Mengzhen
    Wang, Jingyu
    Zhang, Kechun
    MICROBIAL CELL FACTORIES, 2023, 22 (01)
  • [4] Engineering endogenous L-proline biosynthetic pathway to boost trans-4-hydroxy-L-proline production in Escherichia coli
    Jiang, Liangzhen
    Pang, Jing
    Yang, Lixia
    Li, Wei
    Duan, Lili
    Zhang, Guolin
    Luo, Yinggang
    JOURNAL OF BIOTECHNOLOGY, 2021, 329 : 104 - 117
  • [5] A novel strategy for l-arginine production in engineered Escherichia coli
    Mengzhen Nie
    Jingyu Wang
    Kechun Zhang
    Microbial Cell Factories, 22
  • [6] Application of Dynamic Regulation to Increase L-Phenylalanine Production in Escherichia coli
    Wu, Jie
    Liu, Yongfei
    Zhao, Sheng
    Sun, Jibin
    Jin, Zhaoxia
    Zhang, Dawei
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 29 (06) : 923 - 932
  • [7] Enhancing the production of L-proline in recombinant Escherichia coli BL21 by metabolic engineering
    Lu, Jiajie
    Fu, Bing
    Zhu, Zhiwen
    Yan, Chuyang
    Guan, Fuyao
    Wang, Peize
    Yu, Ping
    PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2025, 55 (02) : 187 - 195
  • [8] The Role of ARGR Repressor Regulation on L-arginine Production in Corynebacterium crenatum
    Xu, Meijuan
    Rao, Zhiming
    Dou, Wenfang
    Xu, Zhenghong
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2013, 170 (03) : 587 - 597
  • [9] Metabolic reprogramming and biosensor-assisted mutagenesis screening for high-level production of L-arginine in Escherichia coli
    Jiang, Shuai
    Wang, Ruirui
    Wang, Dehu
    Zhao, Chunguang
    Ma, Qian
    Wu, Heyun
    Xie, Xixian
    METABOLIC ENGINEERING, 2023, 76 (146-157) : 146 - 157
  • [10] L-ARGININE PATHWAY IN THE SEPSIS SYNDROME
    LORENTE, JA
    LANDIN, L
    DEPABLO, R
    RENES, E
    LISTE, D
    CRITICAL CARE MEDICINE, 1993, 21 (09) : 1287 - 1295